Page 37 - Equity Commonwealth News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NEW YORK, NY / ACCESSWIRE / May 24, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:Mackinac Financial Corporation (NASDAQ:MFNC) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Nicolet Bankshares, Inc. Under the terms of the merger agreement, Mackinac shareholders will receive 0.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ALTA, FCBP, MNR, MFNC; Shareholders are Encouraged to Contact the Firm May 20, 2021 00:00 ET | Source: Halper Sadeh LLP Halper Sadeh LLP North Brunswick, New Jersey, UNITED STATES NEW YORK, May 20, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Altabancorp (NASDAQ: ALTA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Glacier Bancorp...

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Equity Commonwealth (NYSE: EQC)...

Equity Commonwealth Purchases Monmouth Real Estate Equity Commonwealth and Monmouth Real Estate Investment Corporation have entered into a definitive merger agreement by which Equity Commonwealth will acquire Monmouth in an all-stock transaction, valued at approximately $3.4 billion, including the assumption of debt. The combined company is expected to have a pro forma equity market capitalization of approximately $5.5 billion. Monmouth’s portfolio is comprised of 120 properties totaling 24.5 million square feet. Equity Commonwealth and Monmouth shareholders are expected to own approximate...

Chiasma, Inc. (NASDAQ: CHMA)  WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Chiasma, Inc. (NASDAQ: CHMA) in connection with the proposed acquisition of the company by Amryt Pharma plc ("Amryt"). Under the terms of the merger agreement, CHMA stockholders will receive 0.396 Amryt American Depositary Shares ("ADS"), each representing five Amryt ordinary shares, for each CHMA share that they own, representing implied consideration of $4.32 based upon Amryt's ADS's May 11, 2021 closing price of $10.90. If you own CH...